Exelixis | EXEL - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 0.87 0.76 0.62 May/05
FY2025Q4 Dec/2025 0.97 0.76 0.55 Feb/10
FY2025Q3 Sep/2025 0.78 0.68 0.47 Nov/04
FY2025Q2 Jun/2025 0.75 0.64 0.84 Jul/28
FY2025Q1 Mar/2025 0.62 0.37 0.17 May/13




Eps Alterar Data
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Akebia Therapeutics USD -0.04 0.04 2025-12
Amgen USD 5.15 0.14 2026-03
AstraZeneca USD 2.58 0.46 2026-03
Bayer EUR 2.71 2.09 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Cytokinetics USD -1.67 0.17 2026-03
Eisai JPY -11.53 72.47 2026-03
Eli Lilly USD 8.55 1.01 2026-03
Esperion Therapeutics USD 0.26 0.42 2025-12
Exelixis USD 0.87 0.1 2026-03
Genmab DKK 3.69 2.77 2025-12
Glaxosmithkline GBP 0.62 0.41 2026-03
Incyte USD 1.81 0.01 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
MacroGenics USD -0.58 0.36 2026-03
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.94 0.06 2026-03
Novartis USD 1.99 0.04 2026-03
Pfizer USD 0.75 0.09 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Sanofi EUR 2.17 2.84 2026-03
Takeda JPY -15.56 81.3 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Xencor USD -1.71 1.62 2026-03